Dr. Moses Godofredo Tomacruz, MD
1502 Parkview Ave, Rockford, IL 61107 • +1-294-555-8751
Medical Education: Accredited U.S. Medical School (Class of 1997)
What This Doctor Actually Performs: CMS Medicare Utilization & Rockford Percentiles
NPI #1144414921 • CBSA Regional • Family Practice
Statistical peer benchmarking across IL Family Practice providers positions Dr. Moses Godofredo Tomacruz, MD in Rockford at -0.09σ (53.85th city percentile / 57.23th state percentile, 329 Medicare beneficiaries), with clinical focus spanning 27 Active CMS HCPCS Codes.
Procedural volume for Dr. Tomacruz is led by HCPCS 99214 (Comprehensive Primary Care & Chronic Protocol Management — 614 annual services, $157–$215 GPCI cash estimate), followed by CPT 99213 (Focused Acute & Preventive Primary Care Evaluation, 453/yr) and CPT G0439 (Annual Wellness Biomarker & Preventive Screening Visit, 175/yr).
Self-pay new patient consultations with Dr. Tomacruz (CPT 99204 GPCI-adjusted benchmark) estimate around $218.00 (community reported average: $218.00) with hybrid in-clinic and telehealth video consults, 10-minute average reception wait, and a 4.91/5 modern protocol openness score across 26 patient logs.
Credentialed as an MD specialist with 29 years post-graduation experience since completing medical school at an LCME/COCA institution (1997), Dr. Tomacruz coordinates 27 Active CMS HCPCS Codes workups from 1502 Parkview Ave (+1-294-555-8751).
Compared against Rockford, IL Family Practice peers
1,539 annual services across 329 beneficiaries
Standard deviations from IL Family Practice mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Comprehensive Primary Care & Chronic Protocol Management | 614 | 53.85th | $157 – $215 |
| 99213 | Focused Acute & Preventive Primary Care Evaluation | 453 | 49.85th | $120 – $164 |
| G0439 | Annual Wellness Biomarker & Preventive Screening Visit | 175 | 50.85th | $180 – $246 |
| 36415 | Routine Venipuncture Blood Biomarker Collection | 132 | 49.85th | $34 – $49 |
| 99204 | New Patient Primary Care Intake & Diagnostic Plan | 88 | 49.85th | $215 – $295 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (27 HCPCS billing breadth) | 77 | 53.85th | $141 – $204 |
Are you Dr. Moses Godofredo Tomacruz? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Rockford, IL:
<a href="https://dotmd.com/doctors/moses-godofredo-tomacruz-md-rockford-il-1144414921" title="Dr. Moses Godofredo Tomacruz, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1144414921.svg" alt="Dr. Moses Godofredo Tomacruz Family Practice Badge" width="280" height="72" /></a>
Dr. Moses Godofredo Tomacruz, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Tomacruz National Provider Identifier | NPI #1144414921 (MD) | CMS NPPES Registry (61107) |
| Dr. Tomacruz Rockford CMS Volume Rank | 53.85th Pct (1,539 CMS svcs; Z -0.088σ) | CMS Medicare Part B (IL Family Practice) |
| Fair Cash-Pay New-Patient Benchmark | $218.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Rockford, IL) |
| Waiting-Room Wait Time & Cash Friendliness | $218.00 avg paid • 10 min lobby wait | 26 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.63/5 Listening • 4.91/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Moses Godofredo Tomacruz
Other High-Volume Family Practice Specialists in Rockford, IL
Ranked strictly by CMS Medicare volumeDr. Tomacruz Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Rockford, IL.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Moses Godofredo Tomacruz community threads and patient logs by age, biological sex, dosage, and treatment duration.